on 10 Sep 2024
Last Applicant/ Owned by
One Kendall Square, Building 600-700
Cambridge
MA
02139
Serial Number
90171690 filed on 10th Sep 2020
Registration Number
7502583 registered on 10th Sep 2024
Correspondent Address
Tiffany D. Gehrke
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Research and development of pharmaceutical products; research and development in the field of bioscience; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders; research and development of pharmaceu Read More
Research and development of pharmaceutical products; research and development in the field of bioscience; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders; research and development of pharmaceutical preparations for the treatment of liver-based disorders, eye disorders and CNS disorders; research and development of oligonucleotide compounds for targeted RNA editing; research and development of oligonucleotide drug platforms for use in the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders
29th Nov 2020
29th Nov 2020
No 90171690
No Service Mark
No 33791/60005
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
10th Sep 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
10th Sep 2024 | REGISTERED-PRINCIPAL REGISTER |
08th Aug 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
08th Aug 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
23rd Jul 2024 | STATEMENT OF USE PROCESSING COMPLETE |
22nd Jul 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
07th Jun 2024 | TEAS STATEMENT OF USE RECEIVED |
07th Jun 2024 | USE AMENDMENT FILED |
30th Nov 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
29th Nov 2023 | SOU TEAS EXTENSION RECEIVED |